TMDX | TransMedics Group, Inc.

Healthcare | Medical Devices | USA | NASD

Index	-	P/E	-	EPS (ttm)	-0.95	Insider Own	1.50%	Shs Outstand	32.26M	Perf Week	3.87%
Market Cap	2.35B	Forward P/E	686.02	EPS next Y	0.11	Insider Trans	-36.31%	Shs Float	30.68M	Perf Month	1.47%
Income	-28.30M	PEG	-	EPS next Q	-0.14	Inst Own	94.80%	Short Float / Ratio	10.76% / 5.61	Perf Quarter	-10.01%
Sales	119.10M	P/S	19.74	EPS this Y	23.40%	Inst Trans	22.14%	Short Interest	3.30M	Perf Half Y	19.75%
Book/sh	5.97	P/B	12.41	EPS next Y	123.40%	ROA	-11.80%	Target Price	88.00	Perf Year	163.48%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-18.30%	52W Range	24.01 - 90.15	Perf YTD	20.04%
Dividend	-	P/FCF	-	EPS past 5Y	-3.60%	ROI	-12.60%	52W High	-17.81%	Beta	1.44
Dividend %	-	Quick Ratio	8.30	Sales past 5Y	64.80%	Gross Margin	68.80%	52W Low	208.58%	ATR	3.27
Employees	212	Current Ratio	9.10	Sales Q/Q	161.60%	Oper. Margin	-19.70%	RSI (14)	50.72	Volatility	3.13% 4.25%
Optionable	Yes	Debt/Eq	0.31	EPS Q/Q	78.40%	Profit Margin	-23.80%	Rel Volume	0.61	Prev Close	72.23
Shortable	Yes	LT Debt/Eq	0.31	Earnings	May 01 AMC	Payout	-	Avg Volume	588.64K	Price	74.09
Recom	1.80	SMA20	0.63%	SMA50	-0.71%	SMA200	19.72%	Volume	360,231	Change	2.58%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight	$48
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral	$15
Apr-07-20	Initiated	Oppenheimer	Outperform	$25
May-28-19	Initiated	Morgan Stanley	Equal-Weight
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy

May-30-23 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-26-23 03:59PM	TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Still Appears To Be Reasonable (Simply Wall St.)
May-08-23 11:21PM	TransMedics Group, Inc. Prices $400 Million of Convertible Senior Notes Due 2028 (PR Newswire)
07:23AM	TransMedics Group, Inc. Announces Proposed Offering of $300 Million of Convertible Senior Notes Due 2028 (PR Newswire)
May-06-23 08:17AM	Rainbows and Unicorns: TransMedics Group, Inc. (NASDAQ:TMDX) Analysts Just Became A Lot More Optimistic (Simply Wall St.)
05:23AM	Loading…
May-05-23 05:23AM	Is TransMedics Group Stock a Buy on the Dip? (Motley Fool)
May-04-23 10:16AM	TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-02-23 12:18PM	Q1 2023 Transmedics Group Inc Earnings Call (Thomson Reuters StreetEvents) -5.18%
May-01-23 05:45PM	TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TransMedics Reports First Quarter 2023 Financial Results (PR Newswire)
08:00AM	TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report (PR Newswire)
Apr-27-23 06:22AM	TransMedics Group (NASDAQ:TMDX) shareholder returns have been enviable, earning 340% in 3 years (Simply Wall St.)
Apr-26-23 10:01AM	Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline (Zacks)
Apr-24-23 10:00AM	TransMedics (TMDX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
04:50AM	Strength Seen in TransMedics (TMDX): Can Its 12.3% Jump Turn into More Strength? (Zacks)
04:05PM	Loading…
Apr-17-23 04:05PM	TransMedics to Report First Quarter 2023 Financial Results on May 1, 2023 (PR Newswire) +5.15%
Apr-06-23 12:48PM	Is Now The Time To Look At Buying TransMedics Group, Inc. (NASDAQ:TMDX)? (Simply Wall St.)
Mar-31-23 12:41PM	Top Small-Cap Stocks for April 2023 (Investopedia)
Mar-21-23 05:16AM	Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait 10 Years (Motley Fool)
Mar-17-23 06:31AM	Market Sentiment Around Loss-Making TransMedics Group, Inc. (NASDAQ:TMDX) (Simply Wall St.)
Mar-08-23 02:50PM	Top Healthcare Stocks for March 2023 (Investopedia)
Feb-24-23 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
10:40AM	Is TransMedics a Good Stock to Buy Right Now? (Motley Fool)
08:58AM	Why TransMedics Stock Was a Big Star This Week (Motley Fool)
06:46AM	Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX) (Simply Wall St.)
Feb-22-23 06:45PM	TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results (PR Newswire)
Feb-21-23 04:05PM	TransMedics to Present at Upcoming March Investor Conferences (GlobeNewswire)
Feb-08-23 04:05PM	TransMedics to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 (PR Newswire)
Feb-07-23 09:53AM	3 Revolutionary Stocks I'd Buy Right Now Without Hesitation (Motley Fool)
04:08PM	Loading…
Feb-02-23 04:08PM	TransMedics Appoints Nick Corcoran as Senior Vice President of Supply Chain and Operations (PR Newswire)
Jan-14-23 05:19AM	3 Explosive Growth Stocks to Buy Now That Could Rocket Higher in 2023 (Motley Fool)
Jan-09-23 08:45AM	3 Breakout Growth Stocks to Buy for the Long Haul (Motley Fool)
Jan-03-23 10:45AM	3 Top Healthcare Stocks Defying the Bear Market (Motley Fool) -7.47%
Jan-01-23 05:26AM	Nasdaq Bear Market: 3 Mind-Blowing Growth Stocks You'll Regret Not Buying on the Dip (Motley Fool)
Dec-28-22 11:58PM	12 Best Performing NASDAQ Stocks in 2022 (Insider Monkey)
05:18AM	Here's My Top Growth Stock to Buy for 2023 and Beyond (Motley Fool)
Dec-27-22 09:04AM	5 Winning Medical Product Stocks That Still Have Room to Run (Zacks)
Dec-21-22 04:05PM	TransMedics to Participate in the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
08:58AM	3 Medical Stocks Creating Wealth Despite Macro Challenges (Zacks)
Dec-08-22 09:40AM	Is Esperion Therapeutics (ESPR) Outperforming Other Medical Stocks This Year? (Zacks)
05:14AM	2 Stocks Up 165% and 209% in 2022 That Could Keep Soaring in 2023 (Motley Fool)
Nov-17-22 12:00PM	TransMedics (TMDX) is a Great Momentum Stock: Should You Buy? (Zacks)
Nov-09-22 06:03AM	TransMedics Group Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-06-22 08:40AM	TransMedics Group (NASDAQ:TMDX) shareholder returns have been stellar, earning 230% in 3 years (Simply Wall St.)
Nov-04-22 07:43AM	TransMedics Clocks Small-Than-Expected Q3 Loss, Boosts FY22 Guidance (Benzinga) +24.00%
Nov-03-22 06:45PM	TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Oct-20-22 04:05PM	TransMedics to Report Third Quarter 2022 Financial Results on November 3, 2022 (PR Newswire)
Oct-04-22 10:15AM	The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare (Zacks) +6.23%
10:04AM	10 Best-Performing Small-Cap Stocks of 2022 (Insider Monkey)
Oct-03-22 09:16AM	3 Resilient Medical Stocks to Watch as Rate Hikes Continue (Zacks)
Sep-21-22 07:41AM	Institutional investors in TransMedics Group, Inc. (NASDAQ:TMDX) lost 9.7% last week but have reaped the benefits of longer-term growth (Simply Wall St.)
Aug-29-22 04:05PM	TransMedics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (PR Newswire)
Aug-04-22 08:19PM	TransMedics Announces Upsize and Pricing of Public Offering of Common Stock (PR Newswire)
Aug-03-22 04:36PM	TransMedics Announces Proposed Public Offering of Common Stock (PR Newswire) +5.61%
Aug-01-22 06:15PM	TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TransMedics Reports Second Quarter 2022 Financial Results (PR Newswire)
Jul-26-22 04:05PM	TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference (PR Newswire)
Jul-18-22 04:05PM	TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022 (PR Newswire)
Jul-17-22 08:04AM	A TransMedics Group, Inc. (NASDAQ:TMDX) insider increased their holdings by 49% last year (Simply Wall St.)
Jul-14-22 10:45AM	Bear Market Winners: 3 Healthcare Stocks That Have Soared More Than 30% This Year (Motley Fool) +5.21%
Jun-25-22 09:00AM	Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High (Motley Fool)
Jun-24-22 06:14AM	Is TransMedics Group (NASDAQ:TMDX) A Risky Investment? (Simply Wall St.)
Jun-03-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-30-22 08:20AM	Investors in TransMedics Group (NASDAQ:TMDX) have made a return of 17% over the past year (Simply Wall St.)
May-07-22 08:08AM	Analysts Are Betting On TransMedics Group, Inc. (NASDAQ:TMDX) With A Big Upgrade This Week (Simply Wall St.)
May-04-22 11:17AM	TransMedics Stock Skyrockets On Increased 2022 Guidance (Benzinga) +40.33%
May-03-22 05:45PM	TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TransMedics Reports First Quarter 2022 Financial Results (PR Newswire)
Apr-28-22 07:00AM	TransMedics Receives FDA PMA Approval of OCS DCD Heart Indication (PR Newswire) +6.52%
Apr-21-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Apr-19-22 06:04PM	TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022 (PR Newswire)
04:05PM	TransMedics Announces the Presentation of New OCS Heart and OCS Lung Clinical Data at the International Society of Heart and Lung Transplantation 2022 Annual Meeting (PR Newswire)
Apr-14-22 07:27AM	Are Institutions Heavily Invested In TransMedics Group, Inc.'s (NASDAQ:TMDX) Shares? (Simply Wall St.) -5.25%
Mar-21-22 07:30AM	TransMedics (TMDX) Soars 9.9%: Is Further Upside Left in the Stock? (Zacks) -5.01%
Mar-01-22 04:05PM	TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference (PR Newswire)
Feb-28-22 04:26AM	TransMedics Group, Inc. (NASDAQ:TMDX) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.) +8.49%
Feb-25-22 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-23-22 06:05PM	TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.27%
04:05PM	TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
Feb-22-22 04:05PM	TransMedics to Present at the Cowen 42nd Annual Healthcare Conference (PR Newswire) -7.59%
Feb-21-22 10:58AM	Analysts Expect Breakeven For TransMedics Group, Inc. (NASDAQ:TMDX) Before Long (Simply Wall St.)
Feb-09-22 04:05PM	TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 (PR Newswire)
Feb-08-22 02:38PM	Skylands Capital, LLC Buys Grand Canyon Education Inc, Owens-Corning Inc, T-Mobile US Inc, ... (GuruFocus.com)
Jan-19-22 09:38AM	Signature Wealth Management Partners, LLC Buys Verizon Communications Inc, Lumen Technologies ... (GuruFocus.com)
Jan-14-22 09:32AM	Is TransMedics Group (NASDAQ:TMDX) A Risky Investment? (Simply Wall St.)
Jan-05-22 06:41PM	TransMedics Announces Publication of OCS Liver PROTECT Trial Results in JAMA Surgery (PR Newswire) -6.57%
Dec-24-21 11:38PM	Federated Hermes Clover Small Value Fund Buys Gray Television Inc, Verint Systems Inc, Veritex ... (GuruFocus.com)
Dec-22-21 07:00AM	TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-17-21 08:38PM	Baillie Gifford Funds Buys Sprout Social Inc, Upwork Inc, TransMedics Group Inc, Sells Cloudera ... (GuruFocus.com)
Dec-01-21 05:09AM	Insider Buying: The TransMedics Group, Inc. (NASDAQ:TMDX) Independent Director Just Bought 49% More Shares (Simply Wall St.)
Nov-11-21 04:05PM	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-09-21 06:15PM	TransMedics (TMDX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	TransMedics Reports Third Quarter 2021 Financial Results (PR Newswire)
Nov-04-21 04:05PM	TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum (PR Newswire) +6.73%
09:57AM	TransMedics Reports Positive Data From OCS DCD Heart Trial (Benzinga)
07:00AM	TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial (PR Newswire)
Nov-02-21 03:01PM	TransMedics (TMDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-26-21 04:05PM	TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021 (PR Newswire)

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gordon Stephen	Chief Financial Officer	May 01	Option Exercise	16.14	5,000	80,700	23,789	May 02 06:31 PM
Hassanein Waleed H	President & CEO	May 01	Sale	78.13	7,500	585,989	559,191	May 02 06:29 PM
Gordon Stephen	Chief Financial Officer	May 01	Sale	79.05	5,000	395,250	18,789	May 02 06:31 PM
Khayal Tamer I	Chief Commercial Officer	Apr 21	Option Exercise	16.14	12,026	194,100	26,401	Apr 25 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Apr 21	Sale	86.28	12,026	1,037,626	14,375	Apr 25 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Apr 21	Sale	90.04	2,775	249,861	17,001	Apr 25 05:00 PM
Hassanein Waleed H	President & CEO	Apr 03	Sale	74.83	7,500	561,196	566,691	Apr 04 05:14 PM
Hassanein Waleed H	President & CEO	Mar 10	Option Exercise	2.21	193,074	426,694	574,191	Mar 14 05:01 PM
Gordon Stephen	Chief Financial Officer	Mar 01	Option Exercise	16.14	5,000	80,700	23,789	Mar 02 05:00 PM
Hassanein Waleed H	President & CEO	Mar 01	Sale	80.72	7,500	605,391	381,117	Mar 02 05:00 PM
Gordon Stephen	Chief Financial Officer	Mar 01	Sale	79.51	5,000	397,550	18,789	Mar 02 05:00 PM
Basile Edward M	Director	Mar 01	Sale	80.10	3,500	280,350	14,314	Mar 02 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Feb 28	Option Exercise	16.14	10,000	161,400	24,375	Mar 02 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Feb 28	Sale	80.15	10,000	801,500	14,375	Mar 02 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Feb 28	Sale	80.06	5,000	400,300	19,776	Mar 02 05:00 PM
Weill David	Director	Feb 27	Option Exercise	14.20	5,934	84,263	15,934	Feb 28 05:01 PM
Weill David	Director	Feb 27	Sale	76.69	5,934	455,100	10,000	Feb 28 05:01 PM
Khayal Tamer I	Chief Commercial Officer	Feb 23	Option Exercise	16.01	35,930	575,405	50,305	Feb 27 08:00 PM
Hassanein Waleed H	President & CEO	Feb 23	Sale	73.65	37,827	2,786,085	388,617	Feb 27 08:00 PM
Khayal Tamer I	Chief Commercial Officer	Feb 23	Sale	73.51	35,930	2,641,114	14,375	Feb 27 08:00 PM
TOBIN JAMES R	Director	Feb 23	Sale	75.13	10,000	751,300	243,591	Feb 27 08:00 PM
Khayal Tamer I	Chief Commercial Officer	Feb 14	Option Exercise	16.00	4,070	65,120	5,370	Feb 16 05:15 PM
Khayal Tamer I	Chief Commercial Officer	Feb 14	Sale	70.15	4,070	285,510	1,300	Feb 16 05:15 PM
Hassanein Waleed H	President & CEO	Feb 14	Sale	70.08	2,173	152,284	389,112	Feb 16 05:06 PM
Gordon Stephen	Chief Financial Officer	Feb 01	Option Exercise	16.14	5,000	80,700	10,714	Feb 03 05:06 PM
Carey John F	VP of Operations	Feb 01	Option Exercise	16.88	1,410	23,806	15,530	Feb 03 05:12 PM
Hassanein Waleed H	President & CEO	Feb 01	Sale	64.21	7,500	481,575	391,285	Feb 03 05:07 PM
Gordon Stephen	Chief Financial Officer	Feb 01	Sale	62.64	5,000	313,200	5,714	Feb 03 05:06 PM
Carey John F	VP of Operations	Feb 01	Sale	63.14	1,410	89,029	14,120	Feb 03 05:12 PM
Khayal Tamer I	Chief Commercial Officer	Jan 23	Option Exercise	16.00	3,142	50,272	4,442	Jan 25 05:36 PM
Hassanein Waleed H	President & CEO	Jan 23	Sale	65.42	12,362	808,664	398,785	Jan 25 05:40 PM
Khayal Tamer I	Chief Commercial Officer	Jan 23	Sale	65.07	3,142	204,450	1,300	Jan 25 05:36 PM
Khayal Tamer I	Chief Commercial Officer	Jan 20	Option Exercise	16.00	5,558	88,928	6,858	Jan 20 06:12 PM
Hassanein Waleed H	President & CEO	Jan 20	Sale	65.19	6,332	412,783	411,147	Jan 20 06:12 PM
Khayal Tamer I	Chief Commercial Officer	Jan 20	Sale	65.21	5,558	362,437	1,300	Jan 20 06:12 PM
Khayal Tamer I	Chief Commercial Officer	Jan 18	Option Exercise	16.00	1,300	20,800	2,600	Jan 20 06:12 PM
Hassanein Waleed H	President & CEO	Jan 18	Sale	65.09	1,306	85,008	417,479	Jan 20 06:12 PM
Khayal Tamer I	Chief Commercial Officer	Jan 18	Sale	65.11	1,300	84,643	1,300	Jan 20 06:12 PM
Gordon Stephen	Chief Financial Officer	Jan 17	Option Exercise	16.14	5,000	80,700	10,714	Jan 18 06:02 PM
Carey John F	VP of Operations	Jan 17	Option Exercise	38.46	1,410	54,229	15,530	Jan 18 05:58 PM
Hassanein Waleed H	President & CEO	Jan 17	Sale	64.14	7,500	481,050	418,785	Jan 18 06:00 PM
Gordon Stephen	Chief Financial Officer	Jan 17	Sale	60.12	5,000	300,600	5,714	Jan 18 06:02 PM
Carey John F	VP of Operations	Jan 17	Sale	62.71	1,410	88,425	14,120	Jan 18 05:58 PM
Khayal Tamer I	Chief Commercial Officer	Jan 13	Option Exercise	16.00	5,900	94,400	7,200	Jan 17 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Jan 13	Sale	60.20	5,900	355,180	1,300	Jan 17 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Jan 03	Option Exercise	16.00	4,100	65,600	5,400	Jan 05 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Jan 03	Sale	61.85	4,100	253,605	1,300	Jan 05 05:00 PM
DAMME LAURA	VP, Clinical Affairs	Dec 15	Option Exercise	38.46	4,990	191,915	4,740	Dec 16 04:30 PM
DAMME LAURA	VP, Clinical Affairs	Dec 15	Sale	59.01	4,990	294,475	0	Dec 16 04:30 PM
DAMME LAURA	VP, Clinical Affairs	Dec 14	Option Exercise	38.46	5,947	228,722	5,947	Dec 16 04:30 PM
DAMME LAURA	VP, Clinical Affairs	Dec 14	Sale	62.43	5,947	371,271	0	Dec 16 04:30 PM
Provost Miriam	VP, Global Regulatory Affairs	Dec 13	Option Exercise	38.46	5,918	227,606	19,469	Dec 15 04:30 PM
Provost Miriam	VP, Global Regulatory Affairs	Dec 13	Sale	62.53	4,315	269,797	15,154	Dec 15 04:30 PM
Provost Miriam	VP, Global Regulatory Affairs	Dec 09	Option Exercise	33.46	5,126	171,500	16,015	Dec 13 04:30 PM
Provost Miriam	VP, Global Regulatory Affairs	Dec 09	Sale	59.00	3,613	213,167	12,969	Dec 13 04:30 PM
Carey John F	VP of Operations	Dec 05	Option Exercise	0.28	36	10	13,844	Dec 05 05:33 PM
Carey John F	VP of Operations	Dec 02	Option Exercise	16.85	23,037	388,250	23,808	Dec 05 05:33 PM
Carey John F	VP of Operations	Dec 02	Sale	63.50	10,000	635,000	13,808	Dec 05 05:33 PM
Gordon Stephen	Chief Financial Officer	Dec 01	Option Exercise	16.14	10,000	161,400	15,714	Dec 05 05:30 PM
Khayal Tamer I	Chief Commercial Officer	Dec 01	Option Exercise	2.21	11,051	24,423	11,051	Dec 05 05:29 PM
Carey John F	VP of Operations	Dec 01	Option Exercise	0.28	3,000	840	3,771	Dec 05 05:33 PM
Gordon Stephen	Chief Financial Officer	Dec 01	Sale	61.30	10,000	613,026	5,714	Dec 05 05:30 PM
Carey John F	VP of Operations	Dec 01	Sale	61.29	3,000	183,873	771	Dec 05 05:33 PM
Lovell Stephanie	Director	Nov 23	Option Exercise	47.82	5,657	270,518	5,657	Nov 23 04:30 PM
Lovell Stephanie	Director	Nov 23	Sale	59.50	5,657	336,592	0	Nov 23 04:30 PM
Lovell Stephanie	Director	Nov 22	Option Exercise	42.98	4,900	210,602	3,800	Nov 23 04:30 PM
Lovell Stephanie	Director	Nov 22	Sale	57.99	4,900	284,130	0	Nov 23 04:30 PM
Khayal Tamer I	Chief Commercial Officer	Nov 15	Option Exercise	2.21	4,254	9,401	5,554	Nov 16 05:00 PM
Hassanein Waleed H	President & CEO	Nov 15	Sale	60.13	14,483	870,863	426,285	Nov 16 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Nov 15	Sale	60.06	4,254	255,495	1,300	Nov 16 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Nov 11	Option Exercise	2.21	2,702	5,971	4,002	Nov 14 07:25 PM
Hassanein Waleed H	President & CEO	Nov 11	Sale	60.03	2,748	164,962	440,768	Nov 14 07:14 PM
Khayal Tamer I	Chief Commercial Officer	Nov 11	Sale	60.03	2,702	162,201	1,300	Nov 14 07:25 PM
Weill David	Director	Nov 10	Option Exercise	16.00	21,645	346,320	35,145	Nov 14 07:17 PM
Weill David	Director	Nov 10	Sale	56.00	21,645	1,212,120	13,500	Nov 14 07:17 PM
Gordon Stephen	Chief Financial Officer	Nov 07	Option Exercise	15.13	10,000	151,259	15,714	Nov 09 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Nov 07	Option Exercise	2.21	3,044	6,727	4,344	Nov 09 05:16 PM
Gordon Stephen	Chief Financial Officer	Nov 07	Sale	56.72	10,000	567,200	5,714	Nov 09 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Nov 07	Sale	60.04	3,044	182,762	1,300	Nov 09 05:16 PM
Hassanein Waleed H	President & CEO	Nov 07	Sale	60.07	2,769	166,334	443,516	Nov 09 05:00 PM
Carey John F	VP of Operations	Nov 01	Option Exercise	0.28	3,000	840	3,771	Nov 03 08:00 PM
Carey John F	VP of Operations	Nov 01	Sale	49.03	3,000	147,084	771	Nov 03 08:00 PM
Gordon Stephen	Chief Financial Officer	Oct 03	Option Exercise	2.21	10,000	22,100	15,714	Oct 04 04:33 PM
Carey John F	VP of Operations	Oct 03	Option Exercise	0.78	3,000	2,353	3,771	Oct 04 04:31 PM
Gordon Stephen	Chief Financial Officer	Oct 03	Sale	41.74	10,000	417,400	5,714	Oct 04 04:33 PM
Carey John F	VP of Operations	Oct 03	Sale	42.09	3,000	126,266	771	Oct 04 04:31 PM
Hassanein Waleed H	President & CEO	Sep 08	Sale	55.37	17,723	981,323	446,285	Sep 09 05:00 PM
Hassanein Waleed H	President & CEO	Sep 07	Sale	55.00	2,277	125,235	464,008	Sep 09 05:00 PM
Provost Miriam	VP, Global Regulatory Affairs	Sep 02	Option Exercise	3.22	2,600	8,372	12,038	Dec 13 04:30 PM
Gordon Stephen	Chief Financial Officer	Sep 01	Option Exercise	2.21	10,000	22,100	15,714	Sep 02 05:00 PM
Carey John F	VP of Operations	Sep 01	Option Exercise	2.21	3,000	6,630	3,771	Sep 02 05:00 PM
Gordon Stephen	Chief Financial Officer	Sep 01	Sale	50.93	10,000	509,300	5,714	Sep 02 05:00 PM
Carey John F	VP of Operations	Sep 01	Sale	51.09	3,000	153,268	771	Sep 02 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Aug 24	Option Exercise	2.21	1,976	4,367	3,276	Aug 25 05:00 PM
Hassanein Waleed H	President & CEO	Aug 24	Sale	50.13	3,591	180,017	466,285	Aug 25 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Aug 24	Sale	50.18	2,514	126,153	24,776	Aug 25 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Aug 24	Sale	50.22	1,976	99,235	1,300	Aug 25 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Aug 23	Option Exercise	2.21	8,024	17,733	9,324	Aug 25 05:00 PM
Hassanein Waleed H	President & CEO	Aug 23	Sale	50.04	16,409	821,106	469,876	Aug 25 05:00 PM
Khayal Tamer I	Chief Commercial Officer	Aug 23	Sale	50.04	8,024	401,521	1,300	Aug 25 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TMDX | TransMedics Group, Inc.

Upgrade your FINVIZ experience